Sponsored Research according to therapeutic area in Malaysia, 2024
Top therapeutic areas of sponsored research conducted in 2024 are in Oncology/Hemato-Onco, ID and Cardiology
Phase breakdown of interventional studies in 2024
Phase III form the largest type of sponsored interventional research, followed by Phase II studies.
Top 10 Sites Based on IEC_IRB Approved Sponsored Research in 2024
Top 10 Trial Sites Based on IEC_IRB Approved Interventional Sponsored Research in 2024
Top Contributors in Number of New Sponsored Research by Sponsors for 2024
AstraZeneca, Merck Sharp & Dohme and Novartis were the top 3 Sponsors in 2024.
Top Contributors in Number of New Sponsored Research by CROs for 2024
IQVIA, PAREXEL and ICON were the top 3 CROs in 2024.
2024 Site Recruitment Achievements in Global Sponsored Trials
